Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart patch lets gut surgery patients go home days earlier

NCT ID NCT07552805

Disease control Sponsor: Rhythm Diagnostic Systems Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 09, 2026 · Updated 3 times

Summary

This study tests a wearable patch called MultiSense that tracks heart rate and other vital signs for five days after a patient leaves the hospital following major digestive surgery. The goal is to see if the patch allows high-risk patients to be discharged earlier while still catching complications early. About 490 adults will be randomly assigned to either the patch or standard follow-up care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 490 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Feb 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : * Adults (aged 18 and over) * Patients scheduled for gastrointestinal surgery : * Major gastrointestinal cancer surgery (pancreas, liver, stomach, oesophagus, rectum) * Colorectal surgery (rectal resection, surgery on the rectum and anus other than rectal resection, minor or major surgery on the small intestine and colon) * Patients in non-critical care with a high risk of post-surgical complications (ASA score 2 or 3) * Patients who have a personal mobile phone and Wi-Fi connectivity at home * Patients who provide written informed consent to participate in the study * Patients who are members of or beneficiaries of a social security scheme * Patients who are proficient in French Exclusion Criteria : * Patients with a contraindication to the use of the device as described in the instructions for use (in particular: known skin allergy to adhesives or silicone, active implantable medical device such as a pacemaker or defibrillator, need for an MRI scan during the intended use of the device, intended application site of the device being tattooed, infected, ulcerated or damaged) * Any other condition which, in the investigator's opinion, would compromise the patient's safety or prevent compliance with the requirements of the protocol * Pregnant or breastfeeding patient * Adult under legal protection (under guardianship, curatorship or judicial protection) * Patient already participating in a clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer digestive system cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Reduction in the initial length of stay

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Amiens-Picardie

    NOT_YET_RECRUITING

    Amiens, 80000, France

  • CHU Charles-Nicolle

    NOT_YET_RECRUITING

    Rouen, Seine-Maritime, 76000, France

  • CHU Reims

    NOT_YET_RECRUITING

    Reims, Grand Est, 51100, France

  • CHU Saint-étienne

    NOT_YET_RECRUITING

    Saint-Etienne, Auvergne-Rhône-Alpes, 42000, France

  • CHU de Besançon

    NOT_YET_RECRUITING

    Besançon, Doubs, 25000, France

  • CHU de Nice

    NOT_YET_RECRUITING

    Nice, Alpes-Maritimes, 06000, France

  • GHND

    NOT_YET_RECRUITING

    Bourgoin, Isère, 38302, France

  • Hôpital Cochin, AP-HP Centre

    RECRUITING

    Paris, 75014, France

  • La Sagesse Mutualist Clinic

    NOT_YET_RECRUITING

    Rennes, Brittany Region, 35000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.